Clinical trials
COVID-19 trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
188 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 112 |
| 2021 | 54 |
| 2022 | 16 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 107 |
| Terminated | 32 |
| Unknown status | 32 |
| Recruiting | 10 |
| Withdrawn | 5 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 8 |
| Instituto Mexicano del Seguro Social | 7 |
| Pfizer | 7 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Hospital Universitario Dr. Jose E. Gonzalez | 5 |
| AstraZeneca | 4 |
| Coordinación de Investigación en Salud, Mexico | 4 |
| Instituto Nacional de Enfermedades Respiratorias | 4 |
| Merck Sharp & Dohme LLC | 4 |
| BioNTech SE | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 188 |
| Coronavirus Infections | 24 |
| Severe Acute Respiratory Syndrome | 11 |
| Pneumonia | 9 |
| Respiratory Distress Syndrome | 7 |
| Cytokine Release Syndrome | 6 |
| Pneumonia, Viral | 6 |
| Virus Diseases | 5 |
| Anxiety Disorders | 4 |
| Acute Kidney Injury | 3 |
Trials
Showing 51 to 75 of 188. Each trial links to its page on Pharma Observatory.
88 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.